Cell-Type Apoptosis in Lung During SARS-CoV-2 Infection
Overview
Authors
Affiliations
The SARS-CoV-2 pandemic has inspired renewed interest in understanding the fundamental pathology of acute respiratory distress syndrome (ARDS) following infection. However, the pathogenesis of ARDS following SRAS-CoV-2 infection remains largely unknown. In the present study, we examined apoptosis in postmortem lung sections from COVID-19 patients and in lung tissues from a non-human primate model of SARS-CoV-2 infection, in a cell-type manner, including type 1 and 2 alveolar cells and vascular endothelial cells (ECs), macrophages, and T cells. Multiple-target immunofluorescence assays and Western blotting suggest both intrinsic and extrinsic apoptotic pathways are activated during SARS-CoV-2 infection. Furthermore, we observed that SARS-CoV-2 fails to induce apoptosis in human bronchial epithelial cells (i.e., BEAS2B cells) and primary human umbilical vein endothelial cells (HUVECs), which are refractory to SARS-CoV-2 infection. However, infection of co-cultured Vero cells and HUVECs or Vero cells and BEAS2B cells with SARS-CoV-2 induced apoptosis in both Vero cells and HUVECs/BEAS2B cells but did not alter the permissiveness of HUVECs or BEAS2B cells to the virus. Post-exposure treatment of the co-culture of Vero cells and HUVECs with a novel non-cyclic nucleotide small molecule EPAC1-specific activator reduced apoptosis in HUVECs. These findings may help to delineate a novel insight into the pathogenesis of ARDS following SARS-CoV-2 infection.
TRIM7 ubiquitinates SARS-CoV-2 membrane protein to limit apoptosis and viral replication.
Gonzalez-Orozco M, Tseng H, Hage A, Xia H, Behera P, Afreen K Nat Commun. 2024; 15(1):10438.
PMID: 39616206 PMC: 11608229. DOI: 10.1038/s41467-024-54762-5.
The Role of the Nrf2 Pathway in Airway Tissue Damage Due to Viral Respiratory Infections.
Kombe Kombe A, Fotoohabadi L, Nanduri R, Gerasimova Y, Daskou M, Gain C Int J Mol Sci. 2024; 25(13).
PMID: 39000157 PMC: 11241721. DOI: 10.3390/ijms25137042.
TRIM7 ubiquitinates SARS-CoV-2 membrane protein to limit apoptosis and viral replication.
Gonzalez-Orozco M, Tseng H, Hage A, Xia H, Behera P, Afreen K bioRxiv. 2024; .
PMID: 38948778 PMC: 11212893. DOI: 10.1101/2024.06.17.599107.
Treeza M M, Augustine S, Mathew A, Kanthlal S, Panonummal R Adv Pharm Bull. 2023; 13(4):678-687.
PMID: 38022818 PMC: 10676557. DOI: 10.34172/apb.2023.069.
Differential activation of programmed cell death in patients with severe SARS-CoV-2 infection.
Riegler A, Benson P, Long K, Leal Jr S Cell Death Discov. 2023; 9(1):420.
PMID: 37985756 PMC: 10662024. DOI: 10.1038/s41420-023-01715-4.